{"filings":[{"id":554720,"accession_number":"0001493152-26-024609","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2026-05-20T20:15:44+00:00","items":["5.02"],"status":"ready","headline":"Director Mike Sayama declines re-election; board shrinks to four, replacement search ongoing","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mike Sayama, independent director, notified SBC he will not stand for re-election at 2026 Annual Meeting.","Board reduced to four members effective before polls open; plans to add fifth independent director afterward.","Departure not due to any disagreement; search for new independent director is underway."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":77361,"accession_number":"0001193125-26-222720","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2026-05-14T10:50:17+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"SBC Medical Q1 revenue falls 9% to $43M; net income drops 47% to $11M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $43M, -9% YoY; net income $11M, -47% YoY; diluted EPS $0.11, -48% YoY.","EBITDA $18M, -26% YoY; net income margin 26% (down 19pp); EBITDA margin 43% (down 10pp).","CEO attributes revenue decline to April 2025 franchise fee restructuring; core business fundamentals remain solid.","Franchise locations rose 33 to 284; LTM customers up 10% to 6.76M; repeat rate 72%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96783,"accession_number":"0001493152-26-018603","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2026-04-23T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"CEO sells 3.1M shares in underwritten secondary offering, company receives no proceeds","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Selling stockholder CEO Yoshiyuki Aikawa offered 3,100,000 common shares; underwriters have 45-day option for additional 465,000 shares.","Company did not sell any shares and received no proceeds from the offering.","Underwriting agreement with Maxim Group LLC as representative filed as Exhibit 1.1.","Offering closed on April 21, 2026.","Shares registered on Form S-3 (File No. 333-292451) filed December 29, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111013,"accession_number":"0001493152-26-013078","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2026-03-27T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"SBC Medical Q4 2025 net income up 117% to $14M; EPS $0.14, revenue $40M (-11% YoY)","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Net income attributable to SBC Medical Group was $14M, up 117% YoY; EPS $0.14, up 133% YoY.","Total revenues $40M, down 11% YoY; EBITDA $14M, down 35% YoY; EBITDA margin 34% vs 46% prior year.","Franchise locations increased 34 to 283; customer count in LTM 6.6M, up 12% YoY; repeat rate 72%.","Return on equity improved to 23%, up 9.8 percentage points YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111012,"accession_number":"0001193125-26-001488","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2026-01-05T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"SBC Medical completes minority investment in U.S. MedSpa chain OrangeTwist, marking U.S. entry","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Strategic minority equity investment in OrangeTwist, a U.S. MedSpa chain with 24 locations across 6 states.","Structured collaboration with OrangeTwist, Hildred Capital and Athyrium Capital to pursue cross-border synergies.","Transaction marks SBC's formal entry into U.S. medical aesthetics market; no financial terms disclosed.","SBC outlines three-phase global expansion roadmap: Entry (2025-2026), Scale (2027-2028), Leadership (2029 onward).","SBC currently supports 258 affiliated clinics globally and manages over 6 million patient visits annually."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127638,"accession_number":"0001493152-25-029699","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2025-12-31T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"SBC Medical announces $20M share repurchase program and effective Form S-3 shelf for up to $50M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Form S-3 shelf registered up to $50M of common or preferred stock, effective Dec 30, 2025; no current offering planned.","Board authorized $20M share repurchase program expiring Dec 31, 2026; open market or private transactions.","Company to use surplus cash and free cash flow for buybacks; program is flexible and can be suspended.","Shelf also registers securities related to Sept 2024 business combination for selling securityholders."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127637,"accession_number":"0001193125-25-318331","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2025-12-15T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SBC Medical gains >50% control of Waqoo via ¥1,900/share tender offer","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Tender offer oversubscribed: 637,817 shares tendered vs 575,000 max; SBC to purchase 575,052 shares at ¥1,900 each (total ~¥1,092.5M).","Largest shareholder Yoshiyuki Aikawa to transfer all remaining shares off-market, pushing SBC ownership above 50%.","Settlement begins December 19, 2025; SBC becomes parent company of Waqoo, a regenerative medicine R&D firm.","Acquisition enhances SBC's healthcare technology capabilities and Japanese market presence."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127636,"accession_number":"0001193125-25-281439","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2025-11-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"SBC Medical Q3 revenue $43M (-18% YoY) but net income jumps 353% to $13M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $43M, down 18% YoY; operating income $16M, up 15% YoY.","Net income attributable $13M (+353% YoY); EPS $0.12 vs $0.03.","EBITDA $17M, margin 38% vs 28%; ROE 23% (up 17pp YoY).","Franchise locations 258 (+34 YoY); customer base 6.5M (+14% YoY)."],"consensus_eps_estimate":null,"consensus_eps_actual":0.36,"consensus_revenue_estimate":null,"consensus_revenue_actual":134040783.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127635,"accession_number":"0001193125-25-278669","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2025-11-13T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SBC Medical Group to acquire Waqoo via tender offer; CEO selling 26.6% stake at discounted price","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["SBCMG to tender for up to 575,000 Waqoo shares at JPY 1,900 each; period Nov 14–Dec 12, 2025.","CEO Yoshiyuki Aikawa to sell his 989,802 shares (26.58%) off-market at JPY 1,445 per share, a discount to tender price.","Post-transaction, Waqoo will become a consolidated subsidiary of SBC Medical Group.","SBCMG currently holds 9.49% of Waqoo; combined with CEO's stake, effective control exceeds 36%.","Strategic rationale: integrate Waqoo's R&D in AGA, orthopedics, skincare, and regenerative medicine."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144417,"accession_number":"0001641172-25-023321","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2025-08-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"SBC Medical Q2 2025 revenue $43M (-18% YoY), net income $2.5M (-87% YoY)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenues $43M, down 18% YoY; income from operations $15M, down 47% YoY.","Net income attributable to SBC Medical $2.5M, down 87% YoY; EPS $0.02 vs $0.20.","EBITDA $15M (46% decrease); EBITDA margin 35% vs 53% prior year.","Franchise locations 259 (+36 YoY); customers 6.31M (+14% YoY); repeat rate 72%."],"consensus_eps_estimate":null,"consensus_eps_actual":0.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":90687548.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144416,"accession_number":"0001641172-25-019984","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2025-07-17T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SBC Medical acquires MB career lounge, adding JUN CLINIC to network","summary_kind":"llm","event_type":"m_and_a","confidence":"medium","bullets":["Acquired MB career lounge, a Japanese consulting/training firm for medical institutions, for undisclosed cash consideration.","JUN CLINIC (5 locations including Shirokane, Ginza) joins SBC's clinic network, diversifying aesthetic services.","Transaction closed July 17, 2025; funded by bank loan; consolidation expected in Q3 2025.","Japan's aesthetic medicine market valued at ¥631B in 2024, growing 6.2% YoY, cited as backdrop.","No purchase price or revenue contribution of target disclosed in filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162772,"accession_number":"0001641172-25-017031","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2025-06-30T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SBC Medical Group added to Russell 3000 Index effective June 30, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Inclusion in the broad-market Russell 3000 Index effective after market open on June 30, 2025.","Membership also includes automatic inclusion in Russell 1000 or 2000 and growth/value style indexes.","About $10.6 trillion in assets are benchmarked to Russell U.S. indexes as of June 2024.","Index membership remains in place for one year under the 2025 reconstitution."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162771,"accession_number":"0001641172-25-015572","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2025-06-18T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"SBC Medical shareholders approve board declassification; all directors to stand for annual election from 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved declassification of board by ~92.7M votes for, 251 against; all directors' terms end at 2026 annual meeting.","Directors Ken Edahiro and Mike Sayama re-elected but will serve only until 2026 due to declassification.","Ratified MaloneBailey LLP as independent auditor for FY 2025 by ~92.7M votes for.","Amended and restated certificate of incorporation filed to reflect board declassification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162770,"accession_number":"0001641172-25-010565","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2025-05-15T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"SBC Medical Q1 revenue down 14% to $47M; net income up 15%; $5M buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $47M (-14% YoY); operating income $24M (-1%); net income $22M (+15%); EPS $0.21 (+5%).","EBITDA $25M (-3%); margin improved to 52% from 46%. Partner clinics 251; customers 6.1M (+14%).","Board approves $5M share repurchase program (May 20, 2025 – May 20, 2026); defers JPY 1B Bitcoin purchase plan.","Begins review of acquiring Risenet (management-support services) from CEO; price and timing not yet determined."],"consensus_eps_estimate":null,"consensus_eps_actual":0.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":47328701.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162769,"accession_number":"0001641172-25-002370","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2025-04-02T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"SBC Medical names Miki Shimizu as Chief Strategy Officer; Komatsu moves to Japan sub role","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board approved on March 27, 2025; effective April 10, 2025.","Miki Shimizu will become Chief Strategy Officer, replacing Akira Komatsu.","Akira Komatsu transitions to Chief of Group Representative Office for SBC Medical Group Co., Ltd. (Japan).","Both roles are within SBC Medical Group Holdings Incorporated or its subsidiary."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":180736,"accession_number":"0001641172-25-001050","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2025-03-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"SBC Medical Q4 revenue down 29% to $44M; FY 2024 net income up 18% to $47M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2024 revenue $44M (down 29% YoY); net income $7M (down 54% YoY); EPS $0.06 (down 58%).","Full-year 2024 revenue $205M (up 6% YoY); net income $47M (up 18% YoY); EPS $0.48 (up 14%).","Q4 EBITDA $21M (down 22% YoY) with margin 47%; full-year EBITDA $89M (up 8% YoY) with margin 43%.","Partner clinics grew by 43 to 251 as of Dec 31, 2024, expanding the clinic network.","Income from operations fell 80% in Q4 to $5M but was nearly flat for the full year at $70M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":180735,"accession_number":"0001493152-25-007047","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2025-02-18T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SBC Medical Group to purchase Bitcoin worth 1 billion yen as treasury diversification","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Purchase of Bitcoin (BTC) equivalent to 1 billion yen, executed through Coinbase, planned February to May 2025.","Decision aims to build robust financial base for long-term enterprise value and hedge against inflation.","Company will continue to prioritize strategic investments while leveraging flexible financial strategies including cryptocurrencies.","Purchase is part of cash management strategy; accounting, tax, and cybersecurity aspects considered."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":197572,"accession_number":"0001493152-24-050895","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2024-12-20T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"SBC Medical to sell ski resort and pilot training units to CEO in related-party deal","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sale of two non-core subsidiaries (Kijimadaira Resort, Skynet Academy) to entities owned by CEO Yoshiyuki Aikawa.","Board and Audit Committee approved; transaction expected to close December 2024.","Kijima shares sold at nominal price due to insolvency; Skynet at immaterial price; impact on book value immaterial.","Company says move concentrates resources on main medical business."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":197571,"accession_number":"0001493152-24-045152","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2024-11-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"SBC Medical Q3 revenue $53M (+12% YoY); net income falls to $2M from $8M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $53M (+12% YoY); operating income $13M (-31% YoY, hit by $12.8M stock-based comp).","Q3 net income attributable to SBC was $2M vs $8M in Q3 2023; nine-month net income $40M (+60%).","Nine-month revenue $160M (+23%), EBITDA $68M (+21%), EBITDA margin 42%.","Partner clinics reached 224 as of Sep 30, 2024, up 24 from a year ago.","Stock-based compensation of $12.8M in Q3 related to listing process reduced operating income."],"consensus_eps_estimate":null,"consensus_eps_actual":0.42,"consensus_revenue_estimate":null,"consensus_revenue_actual":160995005.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":213800,"accession_number":"0001213900-24-080668","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2024-09-20T23:59:59+00:00","items":["1.01","2.01","5.02","9.01","3.03","4.01","5.01","5.03","5.05","5.06","7.01","8.01"],"status":"ready","headline":"SBC Medical Group completes SPAC merger with Pono Capital Two; begins trading on Nasdaq","summary_kind":"llm","event_type":"m_and_a","confidence":"medium","bullets":["Merger closed Sept 17; Pono renamed to SBC Medical Group Holdings Incorporated.","Common stock (SBC) and warrants (SBCWW) began trading on Nasdaq Sept 18.","Total Merger Consideration approx. $1.076 million (as stated in filing; likely intended $1.076B).","Post-merger ownership: public 1.5%, Sponsor 4.8%, former SBC holders 93.7% of 100.7M shares.","CEO Yoshiyuki Aikawa has employment agreement with $12M annual base salary."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":213799,"accession_number":"0001493152-24-034279","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2024-08-29T23:59:59+00:00","items":["5.07","7.01"],"status":"ready","headline":"Shareholders approve Pono Capital Two's merger with SBC Medical Group; closing expected soon","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All proposals passed with >99.9% approval; merger with SBC Medical Group approved by 3,568,722 for, 1,716 against.","Name change to 'SBC Medical Group Holdings Incorporated' and charter amendments approved.","Five directors elected: Yoshiyuki Aikawa, Yuya Yoshida, Ken Edahiro, Mike Sayama, Fumitoshi Fujiwara.","Equity incentive plan authorizing up to 15M shares and Nasdaq issuance of up to 100M shares approved.","Closing of business combination expected in coming days."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":213798,"accession_number":"0001493152-24-033614","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2024-08-23T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Pono Capital Two reports 1.51M shares bought under non-redemption pact; redemptions of 135K shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Holder purchased 1,512,575 shares of Class A common stock at weighted avg price of $11.04 per share.","Redemption deadline passed Aug 21; received redemption requests for 135,471 shares.","Non-redemption agreement aims to help meet Nasdaq listing standards for post-business combination company.","Agreement supports planned business combination with SBC Medical Group Holdings Incorporated."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":213797,"accession_number":"0001493152-24-031176","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2024-08-12T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Pono Capital Two extends deadline for SBC Medical business combination to September 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amendment No. 2 to Non-Redemption Agreement extends Clearance Date (SEC proxy statement review) to September 10, 2024.","Parties agree to close the business combination with SBC Medical Group Holdings on or before September 16, 2024.","Previous Clearance Date was April 30, 2024; extension provides additional time for SEC review."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":233018,"accession_number":"0001493152-24-018277","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2024-05-08T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Pono Capital Two receives two Nasdaq deficiency notices; faces delisting risk","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["On May 6,2024, Nasdaq notified that MVPHS fell below $15M for 34 consecutive days; must regain compliance by Nov 4,2024.","On May 7,2024, Nasdaq notified failure to maintain minimum 400 total holders; must submit a compliance plan within 45 days.","Previously disclosed on Apr 2,2024, deficiency in minimum public shares (1.1M shares); plan due by May 17,2024.","Company is evaluating courses of action but cannot assure regaining compliance with any of the requirements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":233017,"accession_number":"0001493152-24-015696","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2024-04-23T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Pono Capital Two extends merger deadline with SBC Medical to September 30, 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Fourth Amendment to Merger Agreement executed on April 22, 2024.","Outside Date extended from prior deadline to September 30, 2024.","All other terms of the Merger Agreement remain unchanged.","Merger involves Pono, Merger Sub, and SBC Medical Group Holdings Incorporated.","Prior amendments were signed on September 7, October 26, and December 28, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":233016,"accession_number":"0001493152-24-013078","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2024-04-04T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Pono Capital Two receives Nasdaq non-compliance notice for public shares rule","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Notice dated April 2, 2024 for failure to maintain at least 1,100,000 publicly held shares (Nasdaq Listing Rule 5450(b)(2)(B)).","Deadline to submit a plan to regain compliance is May 17, 2024; no immediate effect on trading.","If Nasdaq accepts the plan, it may grant up to 180 calendar days from the notice to cure the deficiency.","If the plan is rejected, the company may appeal to a Nasdaq Hearings Panel."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":251184,"accession_number":"0001493152-24-008595","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2024-03-01T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"Pono Capital Two boosts convertible note to $2.7M; parties release merger claims","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Note purchase price increased from $1.0M to $2.7M per Amended Note Purchase Agreement dated Feb 27, 2024.","Convertible promissory note principal amount raised to $2.7M, maturing on Aug 29, 2024 or upon business combination close.","Note convertible into 270,000 shares of Pono Common Stock (implied conversion price ~$10/share).","Parties released each other from all claims arising from termination of Merger Agreement or failure to close business combination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":251183,"accession_number":"0001493152-24-005383","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2024-02-08T23:59:59+00:00","items":["5.03","5.07","7.01","9.01"],"status":"ready","headline":"Pono Capital Two stockholders approve extension to Nov 9, 2024; 273K shares redeemed, trust at $17.9M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved Charter amendment extending business combination deadline from Feb 9 to Nov 9, 2024.","273,334 common shares redeemed in connection with special meeting.","Trust account balance after redemptions is approximately $17.9 million.","Vote: 4,739,042 for, 213,129 against, 0 abstentions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":251182,"accession_number":"0001493152-24-002794","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2024-01-18T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Pono Capital Two signs non-redemption agreement for up to 1.7M shares to extend business combination","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Non-redemption agreement with unaffiliated investor to purchase 1.5M-1.7M shares in open market at ≤ redemption price.","Investor waives redemption rights; in exchange receives one incentive share per purchased share from target CEO at closing.","Extension amendment seeks to move business combination deadline from Feb 9, 2024 to Nov 9, 2024.","Agreement terminates if SEC comments not cleared by April 30, 2024, or on closing or termination of business combination agreement.","Target is SBC Medical Group Holdings Incorporated; business combination previously announced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":268759,"accession_number":"0001493152-23-046431","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2023-12-29T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Pono Capital Two extends merger deadline with SBC Medical to March 31, 2024","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Third Amendment signed Dec 28, 2023, extending Outside Date from Dec 31, 2023 to March 31, 2024.","Amendment agreed by Pono, Merger Sub, SBC Medical, and representatives; all other terms unchanged.","Original Merger Agreement dated Jan 31, 2023, previously amended June 21, Sept 7, and Oct 26, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":268758,"accession_number":"0001493152-23-038430","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2023-10-26T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Second Amendment to Merger Agreement reduces independent director requirement for SBC designees from two to one","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Amendment dated Oct 26, 2023 modifies Section 5.17(a) of the Merger Agreement regarding post-closing board composition.","SBC now needs only one independent director among its three designees, down from two previously.","Pono's sole designee must now qualify as an independent director (previously no independence requirement).","The mutual designee (Pono and SBC) must still be independent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":285866,"accession_number":"0001493152-23-032156","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2023-09-11T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Pono Capital Two reduces merger consideration for SBC Medical from $1.2B to $1.0B","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Amendment to merger agreement reduces aggregate consideration from $1.2 billion to $1.0 billion.","Other terms of the merger agreement remain unchanged; closing conditions and structure preserved.","Transaction requires stockholder approval; Pono to file proxy statement with SEC.","Pono Capital Two (PTWO) entered into amendment on September 8, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":305797,"accession_number":"0001493152-23-022132","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2023-06-22T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Pono Capital Two amends merger agreement with SBC; narrows target scope and extends deadlines","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amended merger no longer includes SBC's Medical Corporations; only Service Companies and Other Entities.","SBC must deliver disclosure schedules by Aug 31, 2023; Pono can terminate if material adverse items found.","Closing deadline extended from Sep 30 to Dec 31, 2023; Pono absorbs all future extension expenses.","A&R Merger Agreement replaces prior amendments and supersedes expense-sharing provision."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":305796,"accession_number":"0001493152-23-021671","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2023-06-16T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Pono Capital Two extends milestone deadline for SBC merger to June 22","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Amendment No. 3 moves the date for completing disclosure schedules, due diligence, and agreement modifications from June 15 to June 22, 2023.","All other terms of the original merger agreement remain unchanged and in full force.","The proposed business combination with SBC Medical Group Holdings is still subject to stockholder approval and other closing conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":305795,"accession_number":"0001493152-23-019965","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2023-06-02T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"Pono Capital Two issues $1M convertible note to SBC, extends merger agreement deadline to June 15","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["On May 26, 2023, issued $1M convertible promissory note to SBC Medical Group, convertible into 100,000 shares at $10.00/share upon merger close.","Note bears no interest; principal due May 17, 2024 or earlier if merger closes.","On May 30, 2023, extended deadline for completion of disclosure schedules and due diligence from May 31 to June 15, 2023.","Shares issued upon conversion subject to lock-up agreement with six-month minimum period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":305794,"accession_number":"0001493152-23-018332","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2023-05-19T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"Pono Capital Two issues $1M convertible note to SBC Medical Group in merger financing","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Convertible promissory note of $1M issued to SBC Medical Group, convertible into Class A common at $10/share.","Note bears no interest; prepayable anytime; automatically converts at merger consummation.","Closing of note sale must occur by May 31, 2023; issuance exempt under Securities Act Section 4(a)(2).","SBC enters lock-up agreement on converted shares; lock-up from merger close through price/date triggers.","Note purchase supports previously announced merger between Pono Capital Two and SBC Medical Group."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":305793,"accession_number":"0001493152-23-015962","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2023-05-09T23:59:59+00:00","items":["1.01","5.03","5.07","7.01","9.01"],"status":"ready","headline":"Pono Capital Two shareholders approve extension to Feb 2024; 9.6M shares redeemed leaving ~$20M in trust","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Extension Amendment approved at special meeting with 12,147,718 For, 722,941 Against.","Stockholders redeemed 9,577,250 Class A shares; trust account reduced to approximately $20.0 million.","Sponsor converted 2,874,999 Class B shares to Class A on a one-for-one basis per Charter Amendment.","Post-redemption: 5,489,624 Class A shares outstanding, of which 3,566,874 held by initial stockholders not subject to redemption.","Entered non-redemption agreement for 225,000 additional shares; sponsor to transfer common shares post-business combination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":305792,"accession_number":"0001493152-23-015382","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2023-05-04T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Pono Capital Two secures non-redemption agreements for 773,682 shares to support extension vote","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Non-redemption agreements with holders of 773,682 Class A shares; stockholders agree not to redeem for extension vote on May 5, 2023.","Sponsor Mehana Capital will transfer sponsor shares to these stockholders upon consummation of business combination with SBC Medical Group.","Extension proposal would move deadline from May 9, 2023 to February 9, 2024.","No additional funds deposited into trust account; existing trust funds to be used.","The extension vote is scheduled for special meeting on May 5, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":305791,"accession_number":"0001493152-23-014790","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2023-05-01T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Pono Capital Two amends merger agreement with SBC Medical; extends due diligence, adds $1M investment condition","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Amendment extends Pono's due diligence review period from April 28 to May 31, 2023.","Sponsor can now direct earlier or later issuance of 1.2M sponsor shares, at its discretion, but not before closing.","SBC (or affiliate) agrees to invest $1M in sponsor Mehana Capital LLC; investment docs due May 5, payment due May 15.","If investment docs not signed by May 5, either party may terminate merger; if payment not received by May 15, Pono may terminate.","Amendment clarifies extension expenses are paid by Purchaser."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":325090,"accession_number":"0001493152-23-003426","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2023-02-02T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Pono Capital Two enters $1.2B merger with SBC Medical Group Holdings","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Merger consideration of $1.2B, subject to net working capital and debt adjustments.","Restructuring of SBC Japan and affiliated entities required before closing.","Lock-up on shares; 1/3 released at each of $13, $15, $17 stock price thresholds.","Closing conditions include stockholder approvals, SEC review, and Nasdaq listing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":325089,"accession_number":"0001493152-23-003241","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2023-02-01T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Pono Capital Two enters $1.2B merger with SBC Medical Group Holdings","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Entered merger agreement with SBC Medical Group Holdings; Merger Sub to merge into SBC, SBC surviving.","Aggregate consideration value of $1.2B, subject to net working capital, debt, and expense adjustments.","SBC must complete restructuring to bring Japanese entity SBC-Japan and related entities under SBC before close.","Closing requires Pono stockholder approval and other customary conditions; proxy statement to be filed with SEC."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":359490,"accession_number":"0001493152-22-026617","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2022-09-23T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Pono Capital Two announces separate trading of Class A common stock and warrants starting Sept 26","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["11.5 million units sold in August 2022 IPO at $10/unit, gross proceeds $115 million.","Holders may elect to separate units into Class A shares and warrants beginning September 26, 2022.","Unseparated units trade under PTWOU; separated shares under PTWO, warrants under PTWOW."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":359489,"accession_number":"0001493152-22-023329","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2022-08-17T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Pono Capital Two completes $115M IPO and private placement, trust funded at $10.25/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["IPO of 11,500,000 units at $10.00 per unit (including full over-allotment) raised $115M gross.","Private placement of 634,375 units to sponsor at $10.00 each raised additional $6,343,750.","Total net proceeds of $121,343,750 deposited in trust account; redemption value per public share is $10.25.","Audited balance sheet shows $117,875,000 in trust, $951,342 cash outside, and $3,081,544 accumulated deficit.","Must complete a business combination by May 9, 2023 or liquidate; going concern uncertainty noted in audit opinion."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":359488,"accession_number":"0001493152-22-021781","cik":1930313,"company_name":"SBC Medical Group Holdings Inc","ticker":"SBC","form_type":"8-K","filed_at":"2022-08-09T23:59:59+00:00","items":["1.01","3.02","5.03","8.01","9.01"],"status":"ready","headline":"Pono Capital Two closes $115M IPO with full over-allotment; trust funded with $117.9M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["IPO of 11.5M units at $10/unit; gross proceeds $115M.","Underwriters' over-allotment option exercised in full for 1.5M additional units.","Private placement of 634,375 units to sponsor Mehana Capital for $6.34M.","Trust account funded with $117.875M from IPO and private placement proceeds, net of expenses.","Blank-check company targeting technology-driven businesses; led by CEO Darryl Nakamoto."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":318825523.1410256,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}